Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Ager, A.

  • Google
  • 1
  • 9
  • 17

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (1/1 displayed)

  • 2018The eIF2α Kinase Heme-Regulated Inhibitor Protects the Host from Infection by Regulating Intracellular Pathogen Trafficking.17citations

Places of action

Chart of shared publication
Schesser, Kurt
1 / 1 shared
Adkins, B.
1 / 1 shared
Rosen, M.
1 / 3 shared
Aktas, B.
1 / 4 shared
Wn, Khan
1 / 1 shared
Gayle, P.
1 / 1 shared
Jc, Boucher
1 / 1 shared
Shrestha, N.
1 / 1 shared
Bahnan, W.
1 / 1 shared
Chart of publication period
2018

Co-Authors (by relevance)

  • Schesser, Kurt
  • Adkins, B.
  • Rosen, M.
  • Aktas, B.
  • Wn, Khan
  • Gayle, P.
  • Jc, Boucher
  • Shrestha, N.
  • Bahnan, W.
OrganizationsLocationPeople

article

The eIF2α Kinase Heme-Regulated Inhibitor Protects the Host from Infection by Regulating Intracellular Pathogen Trafficking.

  • Schesser, Kurt
  • Adkins, B.
  • Rosen, M.
  • Aktas, B.
  • Wn, Khan
  • Ager, A.
  • Gayle, P.
  • Jc, Boucher
  • Shrestha, N.
  • Bahnan, W.
Abstract

The host employs both cell-autonomous and system-level responses to limit pathogen replication in the initial stages of infection. Previously, we reported that the eukaryotic initiation factor 2α (eIF2α) kinases heme-regulated inhibitor (HRI) and protein kinase R (PKR) control distinct cellular and immune-related activities in response to diverse bacterial pathogens. Specifically for <i>Listeria monocytogenes</i>, there was reduced translocation of the pathogen to the cytosolic compartment in HRI-deficient cells and consequently reduced loading of pathogen-derived antigens on major histocompatibility complex class I (MHC-I) complexes. Here we show that <i>Hri</i><sup>-/-</sup> mice, as well as wild-type mice treated with an HRI inhibitor, are more susceptible to listeriosis. In the first few hours of <i>L. monocytogenes</i> infection, there was much greater pathogen proliferation in the liver of <i>Hri</i><sup>-/-</sup> mice than in the liver of <i>Hri</i><sup>+/+</sup> mice. Further, there was a rapid increase of serum interleukin-6 (IL-6) levels in <i>Hri</i><sup>+/+</sup> mice in the first few hours of infection whereas the increase in IL-6 levels in <i>Hri</i><sup>-/-</sup> mice was notably delayed. Consistent with these <i>in vivo</i> findings, the rate of listeriolysin O (LLO)-dependent pathogen efflux from infected <i>Hri</i><sup>-/-</sup> macrophages and fibroblasts was significantly higher than the rate seen with infected <i>Hri</i><sup>+/+</sup> cells. Treatment of cells with an eIF2α kinase activator enhanced both the HRI-dependent and PKR-dependent infection phenotypes, further indicating the pharmacologically malleability of this signaling pathway. Collectively, these results suggest that HRI mediates the cellular confinement and killing of virulent <i>L. monocytogenes</i> in addition to promoting a system-level cytokine response and that both are required to limit pathogen replication during the first few hours of infection.

Topics